RecruitingNCT06758960
Analysis of Biological Progression and Regression of HELLP Syndrome in Time
Biological Evolution of HELLP Syndrome
Sponsor
CHU Mohammed VI Marrakech
Enrollment
70 participants
Start Date
Jul 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective observational study about progression and regression of biological parameters of HELLP syndrome
Eligibility
Sex: FEMALE
Plain Language Summary
Simplified for easier understanding
This study is analyzing blood test results over time in pregnant women admitted to intensive care with HELLP syndrome — a serious complication of pregnancy involving abnormal blood clotting, liver damage, and a low platelet count — to better understand how this condition develops and resolves.
**You may be eligible if...**
- You are a pregnant woman admitted to a maternal ICU with HELLP syndrome based on blood test findings
**You may NOT be eligible if...**
- Your blood abnormalities are caused by a different condition, such as a blood vessel disorder (microangiopathy) or leukemia
- You have received plasma exchange therapy
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06758960
Related Trials
Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy
NCT072182372 locations
Internal Jugular Vein Collapsibility Index for Volume Status Assessment in Preeclampsia in Correlation With Normotensive Parturients
NCT07786246
Hyperspectral Imaging for Prediction of Preeclampsia
NCT071062941 location
PROTECT-Africa: Biomarker Validation for Preeclampsia Triage
NCT07810439
Vagal Stimulation Therapy and Preeclampsia
NCT069531154 locations